Tim Schlidt
Founder of Palo Santo
San Francisco Bay Area
Overview
Work Experience
Co-Founder & Partner
2020 - Current
Board Member
2022
Ksana Health focuses on collecting data related to mental health and transfer it from users to healthcare practitioners through an app.
Raised $2,000,000.00 from WPSS.bio, What If Ventures, WPSS Investments, BIP Ventures, Telosity Ventures, Able Partners, Apeiron Investment Group, re.Mind Capital and Palo Santo Fund.
Board Observer
2022
Board Observer
2022
Board Observer
2022
Bexson Biomedical is developing a unique formulation of ketamine for chronic and acute pain disorders.
Raised $4,800,000.00 from Lionheart Ventures, PsyMed Ventures and Noetic Fund.
Advisor
2021
Tactogen is a biopharma startup that develops empathogen medicines.
Board Member
2021 - 2023
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Raised $11,100,000.00 from Negev Capital, PsyMed Ventures and Ayuh Ventures.
Private Equity Associate
2017 - 2019
Healthcare Services
Investment Banking Analyst
2015 - 2017
Life Sciences and Healthcare Services
Greenhill & Co is an investment bank providing financial advices.
Raised $20,000,000.00.
Investment Banking Summer Analyst
2014 - 2014
Healthcare Coverage
J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .